Cargando…
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
BACKGROUND: A correlation between plasma CD31+ endothelial microparticles (CD31+EMP) levels and clinical, as well as brain MRI activity, in multiple sclerosis (MS) patients has been previously reported. However, the effect(s) of treatment with interferon-β1a (IFN-β1a) on plasma levels of CD31+EMP ha...
Autores principales: | Sheremata, William A, Jy, Wenche, Delgado, Sylvia, Minagar, Alireza, McLarty, Jerry, Ahn, Yeon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1584221/ https://www.ncbi.nlm.nih.gov/pubmed/16952316 http://dx.doi.org/10.1186/1742-2094-3-23 |
Ejemplares similares
-
Evidence of platelet activation in multiple sclerosis
por: Sheremata, William A, et al.
Publicado: (2008) -
Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study
por: Minagar, Alireza, et al.
Publicado: (2007) -
Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts
Publicado: (1995) -
Sirt6 mRNA-incorporated endothelial microparticles (EMPs) attenuates DM patient-derived EMP-induced endothelial dysfunction
por: Jing, Tong, et al.
Publicado: (2017) -
Differentiation-Associated MicroRNA Alterations in Mouse Heart-Derived Sca-1(+)CD31(−) and Sca-1(+)CD31(+) Cells
por: Wu, Qiong, et al.
Publicado: (2016)